Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Thyroid Year-in-Review 2025-2026: Precision Medicine and De-escalation in Contemporary Thyroidology.

Created on 19 Aug 2026

Authors

Anupam Kotwal, Ana-Maria Chindris, Kaniksha Desai, Omar El Kawkgi, Malini Gupta, Shuchie Jaggi, Rokshana Thanadar

Published in

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. Aug 18, 2026. Epub Aug 18, 2026.

Abstract

The 'Thyroid: Year in Review', presented at the AACE 2026 annual meeting, synthesized practice-influencing peer-reviewed clinical research published between March 1, 2025, and February 15, 2026. This narrative review, based on that presentation, highlights two overarching themes in clinical thyroidology: precision medicine and de-escalation when appropriate. In thyroid dysfunction, recent studies support lean body mass-based levothyroxine dosing and the metabolic integration of liothyronine. The management of thyroid nodules and differentiated thyroid cancer has shifted toward de-escalation, favoring non-surgical interventions, active surveillance for low-risk malignancies, selective omission of radioactive iodine, de-escalation of surveillance strategies, and the complementary use of artificial intelligence with molecular testing to improve diagnostic accuracy in indeterminate nodules. This review summarizes these findings and their implications for contemporary evidence-based endocrine practice.

PMID:
42612910
Bibliographic data and abstract were imported from PubMed on 19 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 12
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement